Vericel Stock Target Price Lowered by Canaccord Genuity Amid Analyst Adjustments
Investment firm Canaccord Genuity Group recently adjusted its price target for biotechnology company Vericel (NASDAQ:VCEL), lowering it from $61.00 to $58.00, while maintaining a “buy” rating on…
Microlise Group Stock Receives Strong Buy Rating from Canaccord Genuity
In a significant development for the Stock Market, Microlise Group (LON:SAAS) has once again secured a coveted “buy” rating from the esteemed investment analysts at Canaccord Genuity…
Canaccord Genuity Reaffirms “Buy” Rating on Flowtech Fluidpower (LON:FLO)
A significant development for investors occurred recently as Flowtech Fluidpower (LON:FLO), a prominent entity in the fluid power industry, saw its “buy” rating reaffirmed by leading financial…